NIU DEQIANG has a total of 13 patent applications. Its first patent ever was published in 2007. It filed its patents most often in United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are CSTONE PHARMACEUTICALS, DEV CT BIOTECHNOLOGY and RQX PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 13 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Peptides | |
#5 | Microorganisms | |
#6 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Niu Deqiang | 13 |
#2 | Wang Zhe | 8 |
#3 | Or Yat Sun | 8 |
#4 | Liu Dong | 5 |
#5 | Sun Ying | 5 |
#6 | Petter Russell C | 5 |
#7 | Singh Juswinder | 5 |
#8 | Moore Joel D | 5 |
#9 | Qiao Lixin | 5 |
#10 | Xu Guoyou | 4 |
Publication | Filing date | Title |
---|---|---|
US2010041674A1 | HCV protease inhibitors and uses thereof | |
US2010041591A1 | HCV protease inhibitors and uses thereof | |
US2008279821A1 | Arylpiperidinyl and arylpyrrolidinyl macrocyclic hepatitis c serine protease inhibitors | |
US2008287449A1 | Aza-tripeptide hepatitis c serine protease inhibitors | |
US2008317712A1 | Arylpiperidinyl and arylpyrrolidinyl tripeptide hepatitis c serine protease inhibitors | |
US2009005387A1 | Quinoxalinyl macrocyclic hepatitis c virus serine protease inhibitors | |
US2008267917A1 | N-functionalized amides as hepatitis c serine protease inhibitors |